bluebird bio Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$236.5M
Lead Investor(s):Goldman Sachs & Co. LLC, BofA Merrill Lynch

Estimated Revenue & Financials

  • bluebird bio's estimated annual revenue is currently $54.6M per year.(?)
  • bluebird bio received $632.5M in venture funding in July 2018.
  • bluebird bio's estimated revenue per employee is $41,037
  • bluebird bio's total funding is $236.5M.

Employee Data

  • bluebird bio has 1330 Employees.(?)
  • bluebird bio grew their employee count by 12% last year.
  • bluebird bio currently has 1 job openings.

We are leading the gene therapy revolution. Our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing - providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. We have a lot of energy, and it's not just the abundance of coffee that keeps us going. Find out what sparks our excitement and inspires us every day.